GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Capex-to-Operating-Cash-Flow

IPAH (Interpharm Holdings) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2007)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Interpharm Holdings's Capital Expenditure for the three months ended in Dec. 2007 was $-0.55 Mil. Its Cash Flow from Operations for the three months ended in Dec. 2007 was $-6.35 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Interpharm Holdings Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Interpharm Holdings's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Capex-to-Operating-Cash-Flow Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.08 - 8.53 -

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Interpharm Holdings's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Capex-to-Operating-Cash-Flow falls into.



Interpharm Holdings Capex-to-Operating-Cash-Flow Calculation

Interpharm Holdings's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Jun. 2007 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-8.003) / -14.105
=N/A

Interpharm Holdings's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2007 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.551) / -6.354
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interpharm Holdings  (GREY:IPAH) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Interpharm Holdings Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings Headlines

No Headlines